
Markey researchers identify genetic marker that could guide brain cancer treatment
LEXINGTON, Ky. (July 25, 2025) — University of Kentucky Markey Cancer Center researchers have discovered a genetic biomarker that could help identify patients with glioblastoma most likely to benefit from the cancer drug bevacizumab. The study, published …